|
|||||
|
|
A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T‐cell lymphomas |
|
| Authors: | Noah Brown Alexandra C. Hristov Nathanael G. Bailey Mark S. Kaminski Tycel Phillips Sumana Devata Tera Mayer Ryan A. Wilcox |
| Affiliation: | 1. Department of Pathology, University of Michigan, Ann Arbor, Michigan;2. Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania;3. Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan |
| Abstract: | |
| Keywords: | |